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ABSTRACT OF PAPERS PRODUCED DURING PhD 
COURSE AND RELEVANT TO THIS THESIS 
 
 
1. Di Bona D, Accardi G, Virruso C, Candore G, Caruso C. Association 
Between Genetic Variations In The Insulin/Insulin-Like Growth 
Factor (Igf-1) Signaling Pathway And Longevity: A Systematic 
Review And Meta-Analysis. Curr Vasc Pharmacol. 2014;12(5):674-
81. Review.  
Abstract 
Some studies have shown that polymorphisms in the insulin growth 
factor-1 (IGF-1) signaling pathway genes could influence human 
longevity. However, the results of different studies are often 
inconsistent. Our aim was to investigate by systematic review and 
meta-analysis the association of the common polymorphisms defining 
the genetic variability of the IGF-1 signaling pathway associated with 
human longevity. Eleven studies investigating the association between 
the polymorphisms in the IGF-1 signaling pathway genes (IGF-1, 
IGF-1 receptor (IGF-1R), Forkhead box O3A (FOXO3A) and Silent 
mating type information regulation 1 (SIRT1) and longevity were 
found and analyzed. The model-free approach was applied to meta-
analyze these studies. No association was reported between the single 
nucleotide polymorphisms (SNPs) of IGF-1 and longevity in the 
available study. The meta-analysis of available data from four studies, 
showed a significant association with the IGF-1R polymorphism 
rs2229765, suggesting that subjects with the A-bearing genotype have 
greater chance of longevity. Concerning the five studies on FOXO3A 
SNPs, for the rs2764264 significant association with longevity was 
observed for C allele when only males were included in the analysis. 
Statistically significant results were obtained for other SNPs as well, 
i.e. rs2802292 ( G allele), rs9400239 and rs479744 (T and A alleles, 
respectively). For rs9400239 the association was observed in male 
long lived with a lower odds ratio than in centenarians while in 
rs479744 it was highlighted a significant association in centenarians. 
Concerning SIRT1, no association between the SNPs under study and 
longevity was observed in the only available report. Current findings 
suggest that both IGF-1R and FOXO3A polymorphisms could be 
associated with longevity. The high degree of between-study 
heterogeneity and the low number of available studies underline the 
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need for further methodologically adequate analyses to confirm these 
evidences. 
 
 
2. Caruso C, Candore G, Accardi G, Virruso C, Di Bona D. Association 
of Klotho polymorphisms with healthy ageing: a systematic review 
and meta-analysis. Rejuvenation Res. 2014 Apr;17(2):212-6. doi: 
10.1089/rej.2013.1523. Epub 2014 Apr 11. Review. 
Abstract 
Nowadays is clearly evident that genetic background constitutes 
integral part of ageing and longevity. Many studies on long lived 
people have been conducted emphasizing the role of certain genes in 
long life. Classic case-control studies, genome wide association 
studies and high throughput sequencing have permitted to identify a 
variety of genetic variants seemingly associated with longevity. Over 
the years, ageing research has focused on insulin/IGF-1 signaling 
pathway because of its evolutionary conserved correlation with life-
span extension in model animals. Indeed, many single nucleotide 
polymorphisms (SNPs), associated with longevity were identified in 
genes encoding proteins that take part in this metabolic pathway. 
Closely related to this pathway is the Klotho gene. It encodes a type-I 
membrane protein expressed in two forms, membrane and secreted. 
The last form acts suppressing oxidative stress and growth factor 
signaling and regulating ion channels and transporters. In particular, 
its over-expression seems to be able to suppress insulin/IGF-1 
signaling extending life span. Thus, our aim was to put together the 
results showed in literature concerning the association between the 
functional variant of KLOTHO "KL-VS" stretch that contains six 
polymorphisms in linkage disequilibrium and successful ageing to 
quantify the possible effect of the variants. The results of our 
systematic review indicate that Klotho KL-VS variant is associated 
with healthy ageing.  
 
 
3. Accardi G, Virruso C, Balistreri CR, Emanuele F, Licastro F, 
Monastero R, Porcellini E, Vasto S, Verga S, Caruso C, Candore G. 
SHIP2: a "NEW" insulin pathway target for ageing research. 
Rejuvenation Res. 2014 Apr;17(2):221-5. doi: 10.1089/rej.2013.1541. 
Abstract 
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Strong evidence suggests that systemic inflammation and central 
adiposity contribute to and perpetuate metabolic syndrome. All of 
these alterations predispose individuals to type 2 diabetes mellitus 
(T2DM), cardiovascular disease, as well as Alzheimer's disease (AD), 
all characterized by chronic inflammatory status. On the other hand, 
extensive abnormalities in insulin and insulin growth factor(IGF)-I 
and IGF-II signaling mechanisms in brains with AD have been 
demonstrated, hence suggesting that AD could be a third form of 
diabetes. The Src homology domain-containing inositol 5-
phosphatase(SHIP)2, has an important role in insulin pathway because 
its over-expression causes impairment of insulin/IGF-1 signaling. 
Since some single nucleotide polymorphisms (SNP) of the gene 
encoding SHIP2, were significantly associated in T2DM patients with 
metabolic syndrome and some related conditions, we decided to 
conduct a case-control study on this gene, analyzing AD and T2DM 
subjects as cases and young, old and centenarians as controls. Our 
results suggest a putative correlation between the rs144989913 SNP 
and ageing, both successful and unsuccessful, rather than age-related 
diseases. Since this SNP is an insertion/deletion of 28 base pairs, it 
might cause an alteration in SHIP2 expression. It is noteworthy that 
SHIP2 has been demonstrated to be a potent negative regulator of 
insulin signaling and insulin sensitivity. Many studies demonstrated 
the association of insulin/IGF1 pathway with ageing and longevity, so 
it is tempting to speculate that the found association with SHIP2 and 
ageing might depend on its effect on insulin/IGF-1 pathway.  
 
 
4. Virruso C, Accardi G, Colonna Romano G, Candore G, Vasto S, 
Caruso C. Nutraceutical properties of extravirgin olive oil: a natural 
remedy for age-related disease? Rejuvenation Res. 2014 
Apr;17(2):217-20. doi: 10.1089/rej.2013.1532. Abstract 
The health benefits of the Mediterranean Diet can be largely ascribed 
to the nutraceutical properties of extra-virgin olive oil (EVOO). 
Monounsaturated fatty acids and various phenolic compounds such as 
oleocanthal, oleuropein, hydroxytyrosol and tyrosol are the main 
nutraceutical substances of EVOO. These substances have been 
suggested to have the ability to modulate ageing- associated processes. 
In experimental models, it was shown that EVOO with high 
concentration of poliphenols has anti-inflammatory and antioxidant 
properties. Indeed, it was observed that hydroxytyrosol, as well as 
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oleocanthal, inhibit the cyclooxygenases (COX-1 and 2), responsible 
for prostaglandin production; oleuropein is a radical scavenger that 
blocks the low-density lipoproteins oxidation. Due to the relevance of 
the olive oil in the economy of Sicily, our group has been funded to 
assess the nutraceutical properties of different kinds of olive oil. 
Indeed, the aim of the study is to evaluate effects of EVOOs, with low 
and high polyphenols content, on the immuno- inflammatory and 
oxidative stress responses in young and old people. Further objective 
of our group is to evaluate effects of EVOO, with low and high 
polyphenols content, on the expression of genes encoding proteins that 
take part in Insulin/Insulin-like growth factor-1 signaling pathway 
involved in longevity. The results of the study will be useful to 
produce olive oil enriched in nutraceutical properties, likely helpful in 
the prevention of age-related diseases. 
 
 
5. Caruso C, Accardi G, Virruso C, Candore G. Sex, gender and 
immunosenescence: a key to understand the different lifespan between 
men and women? Immun Ageing. 2013;10:20.  
Excerpta  
Gender and sex are known to be associated with longevity. While 
males are usually stronger, females live longer. In the Western world, 
the life expectancy of individual born between 2005 and 2010 is 80.4 
for women and 73.4 for men. Potential factors have been examined to 
explain this disagreement. It is possible distinguish advantage in 
longevity related to biological traits and factors related to socio-
cultural characteristics of the population. Males and females have 
different behavioural tendencies, social responsibilities and 
expectation. So, differences in mortality between men and women can 
be not only a matter of sex that refers to biological differences, but 
also a matter of “socially constructed sex”, i.e. gender. One of the 
main interaction between gender and longevity is linked to the kind of 
job. Indeed, in the to-day elderly, professional exposure to stressors 
was stronger in males rather than in females.  
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LIST OF ABBREVIATION 
 
AD Alzheimer’s diseases 
CO Centenarian offspring 
CVD Cardiovascular disease 
EVOO Extra virgin olive oil 
FOXO Forkhead box O 
FMD Fasting Mimicking Diet 
GSK3 Glycogen synthase kinase 3 
GPCRs G-protein-coupled receptors 
HFD High Fat Diet 
IF Intermittent fasting 
IGF Insulin-like growth factor 
IGF-1R Insulin growth factor-1 receptor 
IkB inhibitor of kB  
IkK inhibitor of kB kinase 
IR Insulin resistance 
IRS Insulin responsive substrate 
LLI Long lived individuals 
LPS Lipopolisaccaride 
MUFA Monounsatured fatty acid 
MD Mediterranean diet 
MS Metabolic syndrome 
OR Odd ratio 
PI3K Phosphoatidyl inositol 3-kinase 
PIP2 Phosphoatidyl inositol 2-phosphate 
PIP3 Phosphoatidyl inositol 3-phosphate 
RAS Rat sarcoma protein 
SHIP2 Src homology domain-containing inositol 5-phosphatase 2 
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SIRT1 Silent mating type information regulation 1 
STS Short-Time-Starvation 
SNP Single nucleotide polymorphism  
T2DM Type 2 diabetes mellitus  
TF Transcription factor 
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CHAPTER 1 
 
FASTING AND HEALTHY LIFESPAN FROM 
PROKARYOTES TO HUMANS: FOCUS ON 
INSULIN/IGF-1 PATHWAY. 
 
1.1 INTRODUCTION 
 
Since Hippocrates and Plutarch was quoted as asserting “instead of 
using medicine, rather fast a day”, fasting has been practiced as a 
treatment of many illnesses, but only recently several studies have 
shown the its beneficial effects in adaptive cellular responses that 
reduce oxidative damage and inflammation, optimize energy 
metabolism and enhance cellular protection. 
Many religious groups incorporate periods of fasting into their rituals, 
millions of Muslims refrain from eating or drinking from sunrise 
(Sahur) to sunset (Iftar) during the holy month of Ramadan, which 
lasts between 28 and 30 days. Christians, Jews, Buddhists and Hindus 
traditionally fast on designated days of the week or calendar year. In 
many clinics, patients are now monitored by physicians while 
undergoing water only or very low calorie (less than 200 kcal/day) 
fasting periods lasting from 1 week or longer for weight management, 
and for disease prevention and treatment. Emerging discoveries from 
studies of animal models and humans suggest that the intermittent 
abstinence by food and caloric beverages of as little as 12 hr, 
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intermittent fasting (IF) or 48-120 hr, prolonged fasting (PF), 
improves health effects and protects from diseases processes. In 
rodents, fasting for 24 hr every other day or twice weekly extends 
lifespan up to 30%, independent of both total food intake and weight 
loss (Mattson et al., 2014) and promotes protection against diabetes, 
cancer, heart disease, and neuro-degeneration (Longo and Mattson, 
2014). In humans, IF and less-severe regimens (e.g., consumption of 
approximately 500 kcal/day for 2 days a week) have beneficial effects 
on insulin, glucose, C-reactive protein, and blood pressure (Harvie et 
al., 2011). PF cycles lasting 2 or more days, but separated by at least a 
week of a normal diet, are emerging as a highly effective strategy to 
protect normal cells and organs from a variety of toxins and toxic 
conditions. Raffaghello et al. found that fasting for 48 or more hours 
protects mice and/or normal cells, but not cancer cells from various 
chemotherapy drugs (Raffaghello et al., 2008), while increasing the 
death of many cancer cells type. This effect seems to be dependent in 
part on the reduction of the circulating IGF-1 and glucose levels 
accompanied by authofagy (Lee et al., 2012). Recently, a study has 
shown that, in mice, multiple cycles of fasting modulate 
hematopoietic stem cells protection, self- renewal and regeneration via  
IGF-1 or PKA inhibition (Cheng et al., 2014). Moreover, short-term 
fasting (1–3 days) has been shown to protect rodents against the 
damage induced by ischemia-reperfusion of the liver and kidney, by 
improving insulin sensitivity, reducing expression of markers of 
inflammation and insulin/IGF-1 signaling, and increasing 
cytoprotective gene expression (Hine et., al 2015). Others have 
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reported on the role of PF in causing major decreases in liver and 
body mass in rats (Wasselin et al., 2014). 
The fascinating and potent effect of different kinds of fasting could be 
explained trough the molecular mechanisms of the nutrient-sensing 
pathways connecting nutrition to the ageing process. Interestingly, 
most mutations, capable to extend life-span in a wide range of 
organisms affect proteins that, directly or indirectly, participate in 
nutrient-sensing pathways among them one of the most important is 
the insulin/insulin –like growth factor (IGF-1 pathway). The 
explanation is that these mutations mimic calorie restriction  (CR, a 
dietary regimen based on low calorie intake, usually 30% lower than 
normal without malnutrition), a process well known to be involved in 
life-span extension.  Indeed, literature data obtained using model 
organisms, from prokaryotes to mammals, highlight the role of these 
pathways in life-span modulation (Longo et al 2003). 
 The remarkable effects of the CR on aging and diseases in mice and 
rats are often viewed as responses evolved in mammals to adapt to 
periods of limited availability of food. In these models, reduced 
nutrient signaling is associated with decreased levels of free IGF- 1 
(Fontana and Klein, 2007; Fontana et al., 2010; Masoro, 2005; 
Weindruch and Walford, 1988). The cellular and molecular 
mechanisms responsible for the protective effects of CR have likely 
evolved billions of years earlier in prokaryotes endeavoring to survive 
in an environment mostly or completely deprived of energy sources 
while prevent from age-dependent damage that could compromise 
fitness. In fact, the bacterium Escherichia coli switched from LB, a 
nutritionally peptide rich medium containing glucose, to a calorie-free 
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medium survives 4 times longer than the same strain inoculated in LB 
(Longo and Mattson; 2014); this effect reversed by the addition of 
nutrients but not acetate, a carbon source associated with a starvation 
condition; inasmuch as, mutants as LipA and LpdA, that genetically 
promote aspects of hypoxic metabolism extend the stationary phase 
survival in an hypoxia-inducible factor (ArcA) and acetate- dependent 
manner (Gonidakis et a.l, 2010). The effect of rich medium but not 
acetate in reducing longevity raises the possibility that a ketone body-
like carbon source such as acetate may be part of an “alternate 
metabolic program” that evolved billions of years ago in 
microorganisms and that now allows mammals to survive during 
periods of food deprivation by obtaining much of the energy by 
catabolizing fatty acids and ketone bodies including acetoacetate and 
β-hydroxybutyrate (Cahill, 2006).  
In the yeast S. cerevisiae, fasting extends 2-fold chronological lifespan 
and increases the resistance to multiple stresses (Longo et al.,1997; 
Longo et al., 2012). The mechanisms of nutrients and glucose 
deprivation leading to the lifespan extension involve the 
downregulation of two nutrient-sensing pathways, the amino-acids 
response Tor -S6K (Sch9) and the glucose responsive Ras-adenylate 
cyclase-PKA pathway resulting in the activation of the 
serine/threonine kinase Rim15, a key enzyme coordinating the 
protective responses (Fontana et al., 2010).  The serine/threonine 
kinase Rim15 and the downstream stress resistance transcription 
factors Msn2/4 and Gis1 are required for chronological life span 
extension in mutants with defects in Ras/cAMP/PKA or Tor/Sch9 
signaling as well as in calorie restricted cells (Wei et al., 2008). 
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Notably, when switched to food deprivation conditions, both bacteria 
and yeast enter a hypometabolic mode that allows them to minimize 
the use of reserve carbon sources and can also accumulate high levels 
of the ketone body-like acetic acid (Longo and Mattson, 2014). 
Another major model organism in which fasting extends lifespan is 
the nematode C. elegans. Food deprivation conditions achieved by 
feeding worms little or no bacteria, lead to a major increase in lifespan 
(Kaeberlein et al., 2006; Lee et al., 2006), which requires AMPK as 
well as the stress resistance transcription factor DAF-16, similarly to 
the role of transcription factors Msn2/4 and Gis1 in yeast and FOXOs 
in flies and mammals (Greer et al., 2007). Intermittent food 
deprivation also extends lifespan in C. elegans by a mechanism 
involving the small GTPase RHEB-1 (Honjoh et al., 2009). In flies, 
most studies indicate that intermittent food deprivation does not affect 
lifespan (Grandison et al., 2009). However, food reduction or food 
dilution have been consistently shown to extend Drosophila longevity 
(Piper and Partridge, 2007) suggesting that flies can benefit from 
dietary restriction but may be sensitive to even short starvation 
periods. Together these results indicate that food deprivation can 
result in pro-longevity effects in a wide variety of organisms, but also 
underline that different organisms have different responses to fasting 
(Longo and Mattson, 2014). 
In humans, 12 to 24 hours of fasting typically results in a 20% 
decrease in serum glucose and depletion of the hepatic glycogen, 
accompanied by a switch to a metabolic mode in which non-hepatic 
glucose, fat-derived ketone bodies and free fatty acids are used as 
energy sources. In fact, during prolonged periods of fasting, the brain 
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and other organs utilize ketone bodies in a process termed ketolysis, in 
which acetoacetic acid and 3-β hydroxybutyrate are converted into 
acetoacetyl-CoA and then acetyl-CoA. The ketone bodies are 
produced in hepatocytes from the acetyl-CoA generated from β 
oxidation of fatty acids released into the bloodstream by adipocytes, 
and also by the conversion of ketogenic amino acids (Longo and 
Mattson 2014). These metabolic adaptations to fasting in mammals 
are reminiscent of those described earlier for E. coli and yeast, in 
which acetic acid accumulates in response to food deprivation 
(Gonidakis et al., 2010; Longo et al., 2012). 
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1.2 Genetic variants in Insulin/ IGF-1 pathway and 
prolonged lifespan in humans 
 
Many genetic mutations, in particular single nucleotide 
polymorphisms (SNPs), extend lifespan by acting on Insulin/IGF-1 
pathway. IGF-1, IGF-1 receptor (IGF-1R), Forkhead box O (FOXO) 
3A, Silent mating type information regulation 1 (SIRT1) and 
KLOTHO, all molecules involved directly or indirectly in the 
Insulin/IGF-1 signaling (IIS) are under reflectors for the association of 
their SNPs with ageing and longevity. In human beings, ageing is 
associated with lower IGF-1 circulating levels (Bartke, 2005), and in 
longevous people IGF-1R has been correlated with modulation of 
human lifespan through the attenuation of IGF-1 signaling (Suh et al 
2008). Both IGF-1 and IGF-1R polymorphisms theoretically 
modulating the IGF-1 pathway have been studied for their correlation 
with longevity, but evidences are not conclusive (Suh et al 2008; Xie 
et al 2008; Bonafè et al 2003; Albani et al 2009; Barbieri et al 2012). 
The Insulin/IGF-1 pathway activates the transcription factor (TF) 
FOXO3A which has also been extensively studied for its role in 
longevity. FOXO3A gene, belongs to the family and encodes a TF 
with a typical domain of this family, the forkhead box, a conserved 
DNA-binding domain. It is one of the orthologues of daf-16 in C. 
elegans, a TF involved in stress resistance and longevity (Gems et al 
2003; Kenyon 2005). In addition, FOXO3A interacts with sirtuins, a 
family of histone deacetylase enzymes, with a controversial role as 
anti-ageing molecules in model organisms. SIRT1, one of the seven 
human sirtuin isoforms, SIRT1-SIRT7, deacetylates FOXO3A 
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modulating its response to oxidative stress (Brunet 2004). On the basis 
of findings from experimental models, some human studies south to 
demonstrate an association between specific SNPs involved in 
modulation of Insulin/IGF-1 and longevity. However, the sample size 
of the most of the studies is inadequate and the results are often 
inconsistent.  
The gene Klotho, aptly-named after one of the Greek goddesses Fates, 
believed by ancients to spin the thread of life, encodes a type-I 
membrane protein expresses in two forms, membrane and secreted. It 
was discovered about fifteen years ago, as a gene which, if knocked 
out in mice, leads to a syndrome resembling ageing, including short 
lifespan, while its overespression represses the intracellular response 
triggered by both insulin and IGF-I, leads to longevity extension  
ageing and extends lifespan (Kuro-o  2009, Kuroso 2005). On these 
basis, some studies demonstrated an association between the common 
functional "KL-VS" variant in the KLOTHO (KL) gene and longevity 
in humans. This variant is a stretch that contains six polimorphisms in 
linkage disequilibrium. However, conflicting results of the association 
between “KL-VS” and both ageing and longevity exist (Arking et al 
2002; Novelli et al 2008; Invidia et al 2010; Majumdar et al 2010). 
Another protein that has an important role in  the insulin pathway thus 
presumably in ageing and age-related diseases is SHIP2, the Src 
homology domain-containing inositol 5-phosphatase. The protein 
SHIP2, encoded by the gene inositol polyphosphate phosphatase-like 
1 (INPPL1), catalyzes the degradation of lipid secondary messenger 
PIP3 to produce phosphoatidil inositol 2 phosphate (PIP2). Thus, 
SHIP2 is an antagonist of PI3K. Because the PI3K pathway plays a 
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key role in the biological effects of the insulin, the attenuation of the 
PI3K mediated insulin signaling pathway could be associated with 
insulin resistance (IR) in T2DM and with neuropathology of AD 
(Steen et al 2005; Frisardi et al 2010). Many studies underline the 
role of SHIP2 as probable negative regulator of insulin signaling 
(Ferreira et al 2010; Porte et al 2005; Plum et al 2005; Wozniak et al 
1993). A study conducted by Kaisaki et al in T2DM subjects 
demonstrated  a significant association between SNPs of INPPL1 
(rs2276047, rs9886 and rs144989913 and MS or correlated correlated 
features (Kaiasaki et al 2004).  
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1.3 AIM 1 OF THE THESIS 
 
How discussed previously, fasting and the reduction of nutrient 
sensing pathways signaling increase the lifespan in several model 
organisms. For example, in rodent, fasting for 24 hr every other day or 
twice weekly extends lifespan up to 30%, independent of both total 
food intake and weight loss (Mattson et al., 2014) and calorie 
restriction without malnutrition, reduces insulin/IGF-1 signaling, 
increasing maximal lifespan up to 50%. Indeed, in model animals, 
long term calorie restriction, reduces metabolic factors associated with 
some age-related diseases: oxidative stress, sex hormones and insulin 
levels, adiposity and inflammation (Longo et al., 2010). In human 
beings, ageing is associated with lower IGF-1 circulating levels 
(Bartke, 2005), and in longevous people IGF-1R has been correlated 
with through the attenuation of IGF-1 signaling (Suh et al., 2008). 
Thus, during the first part of my PhD, the aim was to investigate the 
mechanisms involved in modulation of human lifespan focusing the 
attention on the role of the insulin/IGF-1 pathway. For this purpose, 
we explored the literature to summarize the existing data up to date 
and identified through meta-analysis some genetic variants involved in 
the lifespan modulation. The genes considered in our studies encoding 
proteins that take part in the insulin/IGF-1 pathway were:  IGF-1, 
IGF-1R, FOXO3A, SIRT1 and KLOTHO. Moreover, we conducted a 
case- control study to verify the association of two SNPs of SHIP2 to 
two age-related diseases, T2DM and AD. 
 In the following sections we discuss the analysis mentioned above. 
 
17 
 
 
 
 
 
 
 
1.4 ASSOCIATION BETWEEN GENETIC 
VARIATION IN THE INSULIN/INSULIN-
LIKE GROWTH FACTOR (IGF-1) 
SIGNALING PATHWAY AND LONGEVITY: 
A SISTEMATIC REVIEW AND META-
ANALYSIS 
18 
 
 
19 
 
 
20 
 
 
21 
 
22 
23 
24 
25 
26 
27 
28 
 
 
 
 
 
 
 
1.5 ASSOCIATION OF KLOTHO POLYMORPHISMS 
WITH HEALTHYAGEING: A SYSTEMATIC 
REVIEW and META-ANALYSIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
29 
 
 
30 
 
 
31 
 
 
32 
 
33 
34 
35 
36 
 
 
 
 
 
 
 
1.6 SHIP2: A “NEW” INSULIN PATHWAY TARGET 
FOR AGEING RESEARCH 
 
 
 
 
 
 
 
 
 
37 
38 
39 
40 
41 
42 
1.7 DISCUSSION 
 
A growing amount of evidences shows that dietary intervention and 
genetic alterations in gene encoding proteins that take part in 
metabolic nutrient-sensing pathways can modulate lifespan (Bonafè et 
al 2003; Suh et al 2008; Willcox et al 2008; Albani et al 2009; 
Anselmi et al 2009; Flachsbart et al 2009; Soerensen et al 2010; Ziv 
et al 2011). It depends on the hyper o ipo activation of these signaling 
due to genetic mutations that under or over express regulative 
molecules leading to different expression of homeostatic genes.  
During evolution, this pathway has diverged from a single receptor in 
invertebrates to multiple receptors and more complicated pathways 
and regulatory networks in mammals. 
The first signaling cascade associated with ageing and longevity was 
the insulin/IGF-1 pathway in C. elegans. It was shown that mutation 
that reduce the daf-2 function, orthologue of IGF-1 receptor, and 
mutation in age-1, homologue of PI3K, lead to both increased life 
span and stress resistance (Dorman et al 1995; Apfeld et al 1998).  
Also in mice and in primates the modulation of this pathway can 
extend life-span and delay age-related pathologies leading to the 
conclusion that these associations are evolutionary conserved (Bartke 
2005; Anderson et al 2009; Fontana et al 2010).  
Our results, obtained from meta-analyses and candidate gene 
approach, support data previous shown for the role of specific SNPs in 
ageing and longevity. 
Among others, FOXO3A probably represents one of the genes that 
more influence longevity, association observed in different ethnic 
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populations. Moreover, a multitude of studies in C. elegans support its 
role. Daf-16 is the homologue of FOXO in the nematode. Evidences 
demonstrated that it protects cells from oxidative stress that 
constitutes a nerve centre in ageing process, increasing life-span 
(Kenyon 2005). Daf-16 is a TF that modulates the expression of 
SOD2, acting as free radical scavenger (Honda et al 1999). It seems 
that the role of FOXO3A in human might be the same, acting as a TF 
on multiple homeostatic genes in response to decreased insulin/IGF-1 
signaling and consequently increasing life-span (Ziv et al 2011). 
Interestingly, other genes that increase life-span, i.e. the enzymes 
histone deacetylase sirtuins, interact with FOXO. In particular, SIRT1 
deacetylates FOXO3A and modulates its response to oxidative stress 
(Salminen et al 2009).  
Our studies confirm previous studies about the association between 
FOXO3A, IGF-1R and longevity but no association was reported 
between IGF-1 and SIRT1 (for the analyzed SNPs), although, for IGF-
1, its SNPs could affect the serum levels, known to modulate ageing 
and longevity and higher circulating levels of IGF-1 have also been 
associated with longer leukocyte telomere length, a key biomarker of 
human ageing, in healthy subjects (Barbieri et al 2009).  
This would be consistent with the hypothesis that most longevity 
genes have modest or small effect sizes. It is also possible that small 
sample size and the remarkable heterogeneity often observed in the 
populations included in the different studies, in terms of age and 
ethnicity of both control and cases groups, limited our detection 
ability. Another explanation could be that these contrasting results are 
due to the insulin/IGF-1 paradox (Koshiyama 2012).  
44 
Moreover, we observed sex-specific differences in the association of 
the genetic variation with survival during old age. In particular, about 
FOXO3A the significant association with longevity was observed 
specifically when only males were included in the analysis. Also for 
the rs144989913, SNP of INPPL1, we obtain a specific association in 
males. This is not surprising because, as we discussed in our paper 
(Caruso et al 2013), it has been claimed that males and females follow 
different strategies to attain longevity and several association studies 
have been positive only in males (Capri et al 2008). The reason are 
obviously multifactorial, with a socio-cultural component that can be 
distinguish from biological trait linked to longevity. In some cases our 
result became positive only in centenarians. Also this result is not 
surprising, because centenarians represent the survival tail of the 
population (Caruso et al 2012).  
Our second meta-analysis on the association between KLOTHO KL-
VS variant (stretch that contains six polymorphisms in linkage 
disequilibrium) and lifespan indicated a significant association of the 
variant with healthy ageing and longevity, despite the serious 
limitations of the study. This association is limited to KL-VS 
heterozygous people because the KL-VS homozygous undergoes to a 
detrimental effect of the polymorphism indicating a possible 
association mechanism not related to the gene dose. It should be noted 
that in one study the genetic effect was shown only in one population, 
suggesting that genetic or environmental factors could influence the 
observed effect. These contrasting results could be linked to the 
reason mentioned above that partially mask the true genetic effect. 
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However, cross-sectional and prospective studies confirm a genetic 
model in which the KL-VS allele confers a heterozygous advantage in 
conjunction with a marked homozygous disadvantage with low levels 
of HDL cholesterol, high systolic blood pressure, increased risk of 
stroke and early onset coronary artery disease, and mortality (Arking 
et al 2003; Arking et al 2005).  
Coming back to the crucial nodes upstream to insulin/IGF-1 pathway, 
certainly we have to highlight the importance of the second messenger 
PIP3. Indeed, from this molecules start the signal that activate the 
kinase AKT, involved in many crucial cellular activity. To regulate 
PIP3 level, the cell uses a kinase and a phosphatase, PI3K and 
phosphatase and tensin homolog and SHIP2. Since the role of SHIP2 
is the less clear, we analyzed the association of some its SNPs with 
age-related diseases. Variation in SHIP2 levels may cause insulin 
pathway impairment. Indeed, in vivo studies, demonstrated that SHIP2 
is a potent negative regulator of insulin signaling and insulin 
sensitivity (Clement et al 2001; Soeda et al 2010). Since the 
rs144989913 alleles is an insertion/deletion of 28 base pairs, it is 
tempting to speculate that might differently influence gene expression 
of INPPL1. Of course functional studies are mandatory to confirm this 
suggestion but the increased frequency of the deletion allele from 
young to centenarians may be due to a different expression of SHIP2 
that reduce the insulin signaling possibly favoring longevity. 
Summarizing, the studied allelic variants reduce the insulin/IGF-1 
signaling, hence, we agreed that a down regulation of this pathway 
can increase lifespan in human leading to healthy lifespan. 
46 
In rodents, both dietary restriction (DR) and mutations in nutrient and 
growth signaling pathways can extend longevity by 30-50% and lower 
the incidence of age-related loss of function and disease, including 
tumors and neurodegeneration. DR also increases “healthspan” and 
protects against diabetes, cancer, and cardiovascular disease in rhesus 
monkeys, and in humans it causes changes that protect against these 
age-related pathologies (Omodei et al 2011).  
Pharmaceutical interventions that directly regulate nutrient/sensing 
pathways in adults could improve health and prevent age-related 
diseases, but before drugs can be considered for chronic 
administration, it requires large investments. Drastic dietary restriction 
could cause adverse effects especially in old and frail subjects. 
Therefore, an alternative approach might be a close adherence to MD 
that includes an healthy lifestyle. MD is a real culture that has been 
reported to contribute to better health and quality of life in the 
Mediterranean countries. Especially in Sicily and Sardinia, where 
many longevous people exist, this “cultural habit” is common. The 
Elderly Prospective Cohort Study identified a reduced overall 
mortality among old people that live in a “Mediterranean way” and in 
particular in that people consuming monounsaturated (MUFA) fatty 
acid instead of satured (Trichopoulou et al 2005; Bürkle et al 2007). 
Meta-analyses of prospective cohort studies demonstrate that the 
adherence to MD can significantly decreases the risk of mortality from 
CVDs (in particular from coronary heart disease) and the incidence of 
PD, AD and cancer (Sofi et al 2008; Estruch et al 2013). It is well 
established that the pathophysiology of common age-related disease is 
associated with chronic inflammation and oxidative stress and that 
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LDL oxidation is one of the major risk factor for the development of 
CVDs (Candore et al 2010). Extra virgin olive oil (EVOO), the main 
source of polyphenols in MD, is composed by MUFA, mainly oleic 
acid, that reduces LDL cholesterol levels in comparison with saturated 
fats. In vivo, three mechanistic studies have shown that EVOO 
phenolic compounds are able to bind to LDL and this may increase the 
resistance to oxidation. Furthermore, the inhibition of NF-kB pathway 
activation by polyphenols could explain part of its anti-inflammatory 
properties. EVOO also contains carotenoids, sterols, lycopene, and 
hydrophilic phenolics (oleuropein, oleocanthal, hydroxytyrosol and 
tyrosol), all bioactive compounds (Pitozzi et al 2012). In vivo and in 
vitro research has suggested that the dietary intake of EVOO with 
high polyphenols content may attenuate inflammatory response and 
therefore reduce the risk of chronic inflammatory diseases (Corona et 
al 2009; Konstantinidou et al 2010; Khymenets et al 2009). 
Oleuropein is a radical scavenger that blocks the LDL oxidation (de la 
Torre-Carbot et al 2007). Moreover, in vitro studies demonstrated the 
Ibuprofen–like activity of oleocanthal and hydroxytyrosol carried out 
the inhibition of the cyclooxygenases 1 and 2, responsible for 
prostaglandin production, in a dose-dependent manner (Beauchamp et 
al 2005; Gonzalez-Santiago et al 2010). The nutraceutical properties 
of EVOO are summarized in the review  “Nutraceuticals properties of 
Extra virgin Olive oil (EVOO): a natural remedy for age-related 
diseases?”, in the next session.  
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CHAPTER 2 
 
FASTING-MIMICKING DIET (FMD): 
MANIPULATING THE GUT  
MICROBIOTA IN MICE 
 
2.1 INTRODUCTION 
 
How discussed in the Chapter 1, in rodents, both dietary restriction 
(DR) and mutations in nutrient signaling pathways can extend 
longevity by 30-50% and lower the incidence of age-related loss of 
function and disease, including tumors and neurodegeneration. DR 
also increases “healthspan” and protects against diabetes, cancer, and 
cardiovascular disease in rhesus monkeys, and in humans it causes 
changes that protect against these age-related pathologies (Omodei et 
al 2011). In particular, fasting, the most extreme form of DR, can be 
applied in a chronic manner, as intermittent fasting (IF) or periodically 
as cycles of prolonged fasting (PF) lasting 2 or more days. PF are 
emerging as a highly effective strategy to protect normal cells and 
organs from a variety of toxins and toxic conditions (Raffaghello et 
al., 2008; Verweij et al., 2011) while increasing the death of many 
cancer cell types (Lee et al., 2012; Shi et al., 2012). PF causes a 
decrease in blood glucose, insulin, and insulin-like growth factor 1 
(IGF-1) (Lee et al., 2010). Recently, a study has shown that PF causes 
a major reduction in the levels of white blood cells followed by stem 
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cell-based immune system regeneration upon refeeding (Cheng et al., 
2014). However, prolonged water-only fasting is difficult for the great 
majority of the population, and its extreme nature could cause adverse 
effects, which include the exacerbation of previous malnourishments 
and dysfunctions, particularly in old and frail subjects. These concerns 
point to the need for dietary interventions that induce PF-like effects 
while minimizing the risk of adverse effects and the burden of 
complete food restriction. Brandhorst et al.  have identified a plant-
based diet that mimics the effects of fasting (fasting mimicking diet, 
FMD) on markers associated with the stress resistance caused by PF, 
including low levels of glucose and IGF-1 and high levels of ketone 
bodies and IGFBP-1 (Longo and Mattson, 2014). They discovered 
that cycles of the FMD lasting 4 days followed by a standard ad 
libitum diet promotes healthspan in mice. In fact, at the end of the 
FMD and before re-feeding, blood glucose levels were 40% lower 
than those in the control diet group. Throughout the study, glucose 
returned to normal levels within 7 days of re-feeding. Ketone bodies 
increased 9-fold by the end of the FMD but returned to normal levels 
after re-feeding. Serum insulin levels were reduced 10-fold after 4 
days of the FMD and returned to baseline levels after re-feeding. IGF-
1 was reduced by 45% by the end of the FMD period but returned to 
normal levels, even after multiple FMD cycles. IGFBP-1, which 
inhibits IGF-1, increased 8-fold by the end of the FMD regimen, but 
its concentration returned to levels similar to those for ad libitum mice 
within 1 week of re-feeding. These results indicate that FMD cycles 
can have profound effects on visceral fat, glucose, and IGF-1 levels, 
but in mice the latter changes are reversed by the return to the ad 
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libitum diet (Brandhorst et al., 2015). The age-associated decline in 
hematopoiesis causes a diminished or altered production of adaptive 
immune cells, a phenomenon known as ‘‘immunosenescence,’’ 
manifested as a shift in the lymphoid-to-myeloid ratio and elevated 
incidence of anemia and myeloid malignancies (Muller-Sieburg et al., 
2004; Shaw et al., 2010). 4 months of FMD cycles resulted in an 
increase in red blood cell count and hemoglobin levels compared to 
baseline. Complete blood counts indicated that the FMD causes a 
rejuvenation of the blood profile and a reversal of the age-dependent 
decline in the lymphoid-to-myeloid ratio (L/M), as well as of the age-
dependent decline in platelets, and hemoglobin. These results indicate 
that chronic use of the FMD promotes immune system regeneration 
and rejuvenation, in agreement with previous results on the effect of 
fasting on lymphocyte number (Cheng et al., 2014).  Cycles of FMD 
are effective in promoting increases in hematopoietic and 
mesenchymal stem and progenitor cells, which are likely to contribute 
to the regeneration of various cell types/systems. Moreover, FMD 
reduces cancer incidence in C57BL/6J mice, promotes hippocampal 
neurogenesis, improves cognitive performance and increases Median 
lifespan (11% extention). The FMD showed an 18% extension effect 
at the 75% survival point, but only a 7.6% extension effect on the 25% 
survival point and no effect on maximum lifespan. In humans three 
monthly cycles of a 5-days FMD reduced multiple risk factors of 
ageing. In fact, they conducted a pilot clinical trial in healthy adult to 
evaluate the impact of the FMD in humans. The trial included a set of 
19 participants who successfully completed 3 FMD cycles and 19 
partecipants who were randomized to continue on their normal diet 
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and serve as control. The FMD showed to have a beneficial effect in 
the glucose, IGF-1, IGFBP-1, ketone bodies, C reactive protein levels 
and in the percentages of body weight, trunk fat and lean body mass. 
Moreover, the percentage of MSPC in the peripheral blood mono-
nucleated cell population showed a trend (p = 0.1) to increase from 
0.15 ± 0.1 at baseline to 1.06 ± 0.6 at the end of FMD, with a 
subsequent return to baseline levels after re-feeding (Brandhorst et al., 
2015). 
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2.2 Factors influencing the gut microbiota 
 
The human gut microbiota plays a key role in numerous metabolic, 
physiological, nutritional and immunological processes (O’Hara AM 
and Shanan, 2006) and discomposure or disturbance in the functions 
of the microbiome are linked to inflammatory and metabolic disorders 
affecting the human health (O’Toole PW and Claesson, 2010). For 
many years the microbiota has been investigate by using anaerobic 
culture techniques which have provided important information 
concerning the bacteria populations colonizing the human gut (Moore 
and Moore, 1995). However, the classical culture methods are labor-
intensive and time consuming, in addition, the classification and 
identifications based on phenotypic traits do not always allow clear 
results. Molecular techniques based on 16S rRNA sequences 
permitted the detection and identification of bacterial species that are 
difficult to culture, providing power tools to study the microbiome, 
“the organ containing 150-fold more genes than the human genome”. 
(Clarridge J. 2004; Vanughan et al., 2000; O’Sullivan et al., 2000; 
Dethlefsen et al., 2006).   The microbial content changes along the 
length of the gastrointestinal tract (GIT), varying from a attenuated 
diversity and a low numbers of microbes in the stomach to a wide 
diversity and high numbers in the large intestine (Tiihonen et al., 
2010). The human intestine is populated by 10
13
 to 10
14
 micro-
organisms, the vast majority of which belong either to the phylum 
Firmicutes or to the phylum Bacteroides including Lactobacillus, 
Clostridium, Ruminococcus, Enterococcus, Bacteroides and 
Prevotella which constitute over 90% of the known philogenetic 
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categories found in the human intestine (Qin et al., 2010; Eckburg et 
al., 2005; Wang et al., 2003). Since the gestation mother, several 
factors influence the microbiome composition because the flora 
originates in the canal birth where bacterial populations, inhabiting the 
maternal vaginal, colonize the intestine. Initially, facultative anaerobes 
such as Enterobacteriaceae, streptococci and staphylococci dominate 
(Marque et al.,, 2010). For infants delivered by cesarean section, the 
environment such as nursing tools and the air, is the dominant source 
of colonizing microorganisms impacting on the intestinal flora with a 
lower bacterial counts and less diversity than in infants born vaginally 
(Grolund, 1999). Another factor influencing the composition of the 
microbiota in the early infancy is the newborn feeding. The 
microbiota of formula-fed infants includes Enterobacteriaceae, 
Streptococcus, Bacteroides, Clostridium and Bifidobacterium, against 
the microbiota of breast-fed infants is dominated by Bifidobacterium 
and Ruminococcus with ratios of colonization by Escherichia coli, 
Clostridium difficile, Bacteroides Fragilis group and Lactobacilli 
being significantly lower than those found in the formula-fed infants 
(Penders J, et al 2006; Favier et al, 2002). However, the intestinal 
microbiota in early infancy is characterized by instability and its 
composition changes further with the introduction of solid food, 
becoming more stable, similar to the adult, after 2-3 years of age 
(Yatzunenko T et al, 2012; Favier C et al, 2002). Although the 
intestinal microbiota is relatively stable throughout adulthood, age –
related changes in the gastrointestinal tract (GIT), as well as changes 
in diet and host immunity reactivity, inevitably affect bacteria 
population composition (Delgado S et al, 2006). The normal intestine 
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microbiota is important for the maintenance of the host health, 
providing energy in the form of short-chain fatty acid (SCFAs) 
(Cummings et al., 1997), nutrients such as vitamins K and B12 
(Deguchi et al 1985) and protection against invading microorganisms 
by exerting colonization resistance  (Van der Waaij et al 1971; Rolfe 
1997).  Physiological changes, as decreased intestinal motility and 
slow transit times, occur in the GI tract of elderly people, resulting in 
a reduction of the faecal weight and reduced excretion of bacterial 
matter (Woodmansey et al, 2004; Stephen et al, 1987). The prolonged 
retention time leads to an increase in bacterial protein fermentation 
and consequently putrefactive processes in the gut with a greater 
susceptibility to disease (Macfarlane et al, 1989). Changes with age in 
specific bacterial genera and species have been identified, with a 
considerable inter-individual variation that continues into old age 
(Claesson MJ et al, 2011). Many studies have shown a decline, with 
the increased age, in counts of Bacteroides and Bifidobacteria, either 
in the total numbers and in the species diversity, that is amplified 
consequently to the antibiotic therapy (Hopkins and Macfarlane, 
2002; Woodmansey, 2004; Bartosch et al. 2004). Bacteroides, being 
able to utilize a wide variety of different carbon sources, are 
responsible for the majority of polysaccharide digestion in the colon 
(Salyers 1984; Macfarlane and Gibson, 1991), accordingly, the 
decreased Bacteroides species level correlates with a reduction in 
amylolytic activity observed in healthy elderly population 
(Woodmansey E.J et al. 2004). In concomitance to the shifts observed 
in the genus Bacteroides, the decreasing of the beneficial 
bifidobacteria levels is one of the most notable changes in the elderly 
60 
gut. A wide number of bifidobacterial species are observed in infants 
and young adults, however, only few species are found in the elderly 
population, in particular Bifidobacterium adolescentis and 
Bifidobacterium longum (Gavini et al., 2001). Moreover, evidences 
support an increase in the number of facultative anaerobes, 
fusobacteria, clostridia and eubacteria, with a rise in the proteolityc 
activity, particularly following antibiotic treatment (Woodmansey; 
2007). These changes in the microbial composition can be linked to 
the increased serum antibodies levels to commensal microorganisms, 
such as Escherichia coli and Enterococcus faecalis, in a healthy adult 
population (Percival et al. 1996). A study conducted by the 
ELDERMET consortium reports that the microbial population of 
elderly Irish subjects is dominated by Bacteroides against the 
microbiota of younger subjects dominated by Firmicutes (Claesson et 
al. 2011). However, significant differences have not been found 
among the Firmicutes:Bacteroides ratio of Italians centenarians, 
elderly and young adults (Biagi et al. 2010). These conflicting results 
can be attributed to the country- related variation in the composition 
of the microbiota as well as the different residence locations, which 
reflect two radically different diets (Biagi et al. 2012; Claesson et al. 
2011). 
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2.3 Macrobiota: Diet and genetic 
 
Mammals exhibit marked inter-individual variations in their gut 
microbioma and the host genotype has a measurable impact on gut 
microbiota composition in both mice (Benson et al., 2010) and 
humans (Goodrich et al., 2014); but comparisons of human twins at 
various ages, from infants to adults, have failed to detect significantly 
more similar microbial communities in monozygotic versus dizygotic 
pairs, suggesting that environmental factors predominate over host 
genetics in shaping microbial ecology. (Turnbaugh et al., 2009; 
Yatsunenko et al., 2012).  
Diet is known to modulate the composition of the microbiota in 
humans and mice. David et al. show that the short-term consumption 
of diets composed entirely of animal or plant products alters microbial 
community structure and overwhelms inter-individual differences in 
microbial gene expression. (David et al., 2014) 
Time series analyses of inbred mice have shown that the consumption 
of a high-fat, high sugar (HFHS) diet alters the gut microbiota in a 
single day (Turnbaugh et al., 2009; Zhang et al., 2012) and the 
microbial response to the consumption of the HFHS diet overshadows 
preexisting genetic association. Male C57BL/6J wild type mice, and 
animals homozygous for mutations in four genes, that have been 
previously shown to impact the gut microbiota, were fed a low- fat, 
high-plant-polysaccharide (LFPP) diet for 4 weeks at which point they 
were switched to the HFHS for 1 week. Analysis of microbial 
community structure over time revealed that all genotypes responded 
within 2 days. The microbial response seems to be proportional to the 
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degree of dietary perturbation when the mice are fed with different 
percentages HFHS by weight. Moreover, the abundance of taxa 
depends on numbers of prior shifts diet. Analysis of the consecutive 
dietary shifts in outbread mice suggested that both community 
membership and structure were markedly altered after 3-7 days of 
HFHS diet consumption in naive mice, whereas the gut microbiota of 
mice previously exposed to the HFHS diet took 1-2 weeks to respond 
(Carmody et al., 2015). Changes in the composition of the gut 
microbioma in response to dietary intake occur most because different 
bacterial species are better equipped to utilize different substrates 
(Scott KP et al., 2008). Generally bacteria prefer carbohydrates as 
primary energy sources if they are available (Apajalahti et al., 2005).  
Analysis of fecal short-chain fatty acid (SCFAs) and bacteria clusters 
suggests that macronutrient shifts on plant-based diet and animal-
based diet also alter microbial metabolic activity. Correlating subject’s 
SCFA concentration with bacterial clusters, it was observed 
significant positive correlation between clusters composed of 
putrefactive microbes and SCFAs that are the end products of the 
amino acid fermentation (Alistipes putrenidis and Bacteroides) and 
clusters comprised of saccharolytic microbes, for example, 
Rosesburia, E rectale and F. prausnitzii, and the products of 
carbohydrate fermentation. (David et al., 2014). Saccharolytic and 
proteolytic bacterial fermentation take place mainly in the proximal 
and distal colon, respectively, and result in the production of SCFA 
and in addition to ammonia, amines, phenols, thiols and indoles in 
theamino acid fermentation (Guarner and Malagelada, 2005).  
However, the plant-and animal-based diet reflect transcriptional 
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response that are consistent with differences in gene transcription 
between the gut microbiomes of herbivorous and carnivourous 
mammals. For example the animal- based diet was associated with 
significant increase in bacterial gene expression among glutamine 
amido transferases (Vitamin B6), methyltransferase (polycyclic 
aromatic hydrocarbon degradation) and beta-lactamase. (David et al. 
2014). 
SCFAs produced from microbial fermentation affect proliferation, 
differentiation and modulation of gene expression in mammalian 
colonic epithelial cells. These effects have been attributed to butyrate 
acting as a potent histone deacetilase inhibitor and, as such, it may 
regulate 2% of the mammalian transcriptome. SCFAs can regulate 
gene expression by binding to the G-protein-coupled receptors 
(GPCRs), GPR41 and GPR43. SCFAs suppress inflammation through 
GPR43 signaling in immune cells and modulate secretion of the 
hormone GLP1, which improves insulin secretion and has antidiabetic 
effects. (Tremaroli and Backhed, 2012 ). 
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2.4 AIM 2 OF THE THESIS 
 
Reduced food intake, avoiding malnutrition, can ameliorate aging and 
aging-associated diseases in invertebrate model organisms, rodents, 
primates, and humans. These effects seem to be dependent in part on 
the reduction of the nutrient signaling pathways associated with 
decreased circulating IGF-1 and glucose levels Modulation of the gut 
microbiota through the diet can also be important to promote healthy 
effects in the organisms (Fontana and Partridge, 2015).  The human 
intestinal microbiota plays a fundamental role in numerous metabolic, 
physiological, nutritional and immunological processes and 
manipulating the gut microbiota may result in modification of 
functionality of an aged immune system (O’Hara and Shanan, 2006). 
Diet is known to modulate the composition of the microbiota in 
humans and mice. Long-term dietary intake is known to influence the 
structure and the activity of the trillions of microorganisms in the 
human gut, but it remains unclear how rapidly and reproducibly the 
human gut microbiome responds to short-term macronutrient change. 
David et al. show that the short-term consumption of diets composed 
entirely of animal or plant products alters microbial community 
structure and overwhelms inter-individual differences in microbial 
gene expression (David et al 2014). 
During the last year and half of my research activity, carried out at the 
"Longevity Institute" of the "University of Southern California", I 
examined the effect of the dietary intervention on the gut micro 
biome, with the main aim to define a common bacteria profile 
correlated to the short–time starvation (STS) and fasting- mimicking 
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diet (FMD).  In the first phase of the project, I designed a study to 
determine the time points, relating to the collection of fecal samples, 
and in order to standardize a suitable method that allowed me to 
quantify the bacterial species of interest. Bacterial groups and species-
specific were quantified in each group (see details below)  using a 
quantitative real- time PCR (qPCR) based on previously published 
specific primers for total bacteria (HAD primers), Bifidobacterium 
group, Enterobacteriaceae, Prevotella group, Lactobacillus, 
Faecalibacterium prausnitzii, Eubacterium rectale and Rosesburia 
intestinalis, designed on the gene coding for 16S ribosomal subunit.  
After the study described above, I examined the effect of short-term 
starvation (STS) and fasting- mimicking diet (FMD) in the gut 
microbiota of  a “nude mouse” model to test the effects of the diets in 
the gut microbiota in an immune-deficient condition. At the end, I 
tested the FMD effect in wild-type, 18 months- old, mice. 
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2.5 RESULTS 
 
To define a bacterial profile correlated to the Short time starvation 
(STS) and fasting-mimicking diet (FMD), I considered two different 
conditions that differ by age and chow food in which the STS and 
FMD have previously shown to have an effect in the mice. In the first 
experiment, 3 groups of C57BL/6J wild-type female mice, 12-weeks 
old, were fed: Group1: Mice undergo with regular food ad lib (control 
diet); Group2: Mice undergo cycles of 4-days  FMD; Group3: Mice 
undergo cycles of 48h short-time starvation (STS). 
The fecal samples have been collected from the cages of each group of 
mice the last day of the 2° cycle FMD/STS and at the same time point 
of the control diet (ad lib). (See table 1) 
 
Table 1: Real- time PCR quantization of 16S rRNA gene in feces of mice 12- week old  
a.Mean: indicates the mean value of the two Ct values 
b.SD: indicates the standard deviation of the Ct values 
c.N(ng/ul): indicates the value obtained through standard curves created with a “control 
sample”of known concentration 
d.N-fold: indicates the value N divided the total bacteria value respect to the control 
 
Of the groups and species analyzed, Enterobacteriaceae increases 
176,60-fold respect to the control group the last day of the 2° cycle of 
FMD and 173,36- fold the last day of the 2° cycle of STS. 
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Bifidobacterium group seems increased of around 6-fold respect to the 
control after the 2° cycle of the FMD, the others species seem 
decreased or not change after dietary intervention. 
 In the second experiment 4 groups of C57BL/6J wild-type female 
mice, 16-months old: 
 Group1: mice undergo High Fat Diet (HFD); Group2: Mice fed with 
HFD and undergo cycles of FMD (5 days + 2 days of standard diet) 
and return to dietary regimen HFD for 3 weeks; Group 3: Mice fed 
with Standard diet. 
The fecal samples have been collected the day before the 9° FMD 
cycle (Before FMD), after 5 days FMD (+ 2 days Standard diet) and at 
the same time points of Standard and High fat diet. (See table 2). 
  
Table 2: Real- time PCR quantization of 16S rRNA gene in feces of mice 16- months old  
 
a.Mean: indicates the mean value of the two Ct values 
b.SD: indicates the standard deviation of the Ct values 
c.N(ng/ul): indicates the value obtained through standard curves created with a “control 
sample”of known concentration 
d.N-fold: indicates the value N divided the total bacteria (relative abundance) and respect to 
the Group1 HFD 
e.N-fold: indicates the value N divided the total bacteria (relative abundance) and respect to 
the Group2 Before FMD 
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The total bacteria related to the HAD primers seem decreased 0,20-
fold after FMD respect to the Group 2 Before FMD; the amount of 
Lactobacillus, equal in the Group 1 and in Group 2 Before FMD, 
drops down the last day of FMD (0,01-fold). The abundance of 
Bifidobacterium increased 7,07-fold at the end of the FMD respect to 
the Group 2 Before FMD and the abundance of Enterobacteriaceae 
was higher  9,40-fold in the Group 2 respect to the Group 1. The 
amounts of all species and groups were considerably lower in the mice 
undergo the Standard Diet (Group 3). 
After evaluating the effectiveness of the method and considering some 
adjustments for the sample collection, I examined the effect of the 
STS and FMD in the gut microbiota of a “nude mouse” model. 
Therefore, I designed an experiment involving 20 mice athymic, 
Balb/C: 5 mice undergo 3-days FMD followed by 7 days of a regular 
dietary regimen (re-feeding, RF); 5 mice undergo 48hr STS followed 
by 7 days of re-feeding (RF); 5 mice undergo 3-days FMD and 5 mice 
undergo 48hr STS.  
The mice treated with STS and FMD have lost ~ 20% weight during 
2- days STS and 3-days FMD and reached the initial weight after 7 
days re-feeding. The body’s weight has been measured every day 
during the diets and after 7 days re-feeding. (See figures below). 
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      A)          
                      
 
                              
       B) 
                               
  
Figure 1.A.Weight loss percentage in mice undergo STS from day2 to the day4 and in mice undergo 
FMD. B. Weight loss during the diets and regained after 7 days re-feeding (RF) 
 
The bacterial species quantified in this study are: Total bacteria, 
Lactobacillus, Bifidobacterium, Enterobacteriaceae and 
Faecalibacterium prausnitzii. The fecal samples have been collected 
at the Baseline, before the dietary intervention and at the end of the 
treatments (STS, FMD, STS-RF, FMD –RF). (See Figures below). 
The samples have been analyzed contemporary for every fecal specie 
investigated. 
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Figure 2. au: indicates arbitrary unit; amount obtained in 0,1 gr of stool. The amount was 
calculated for each mouse, and the geometric mean was determined for each group. 
A non parametric Mann-Whitney U test was used for the comparison of the groups. 
Bars represent the geometric mean. *, significant difference(p<0.05) between groups Baseline 
and FMD;***, significant difference between Baseline and STS. 
Linear scale in the Y axis. 
 
 
The total bacteria amount decreased after treatment 48hr STS 
(significant reduction; p=0.0008) and tends to reach the initial level 
after 1 week re-feeding (STS-RF); also the treatment FMD acts by 
decreasing the number of total bacteria (significant reduction; 
p=0.048), which does not reach the initial levels after 7 days re-
feeding (FMD- RF). 
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Figure 3.au: indicates arbitrary unit; amount obtained in 0,1 gr of stool. The amount was calculated for 
each mouse, and the geometric mean was determined for each group. 
Bars represent the geometric mean. Log-scale in the Y axis. 
 
The abundance of the specific rRNA genes were calculated for each 
mouse, and the mean of each mice group was determined to assess 
reductions or increase in certain bacterial populations after dietary 
interventions. The abundance of  Lactobacillus was significantly 
lower in stool samples from both groups STS (p=0.0113) and FMD 
(p=0.0111), compared to “Baseline” results, and  reaches the initial 
levels in the STS-RF and FMD-RF mice.  
As it regards the group Bifidobacterium, Fasting-mimicking diet acts 
more, compared to Short-time starvation, in reducing the quantity 
which increases considerably after re-feeding (FMD vs FMD-RF 
p=0.0357). It also notables that the amount of Enterobacteriaceae 
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found to be increased in the groups STS and FMD, becomes lower 
and more consistent after 7 days of the regular diet. The diets seem to 
have no significant effects on Facaelibacterium prausnitzii. These 
data show that the Short-time starvation, STS, and Fasting-mimicking 
diet, FMD, manipulate the gut microbiota in the “nude mice” (Figure 
3). 
At the end, I tested the effect of the FMD in the gut microbiota of 
C57BL/6J , 18- months old mice. This time, I considered 3 time points 
with 3 groups of 4 mice each: FMD-i : mice undergo 2 cycles 4-days 
FMD, FMD-i-14dRF: mice undergo 2 cycles 4 -days FMD followed 
by 14 days re-feeding, FMD-i-34dRF: mice undergo 2 cycles 4-days 
FMD followed by 34 days re-feeding. In every time point considered, 
I collected the fecal sample in a control group fed with an ad libitum 
diet to compare the results. 
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Figure 4. au: indicates arbitrary unit; amount obtained in 0,1 gr of stool.  
The amount was calculated for each mouse, and the geometric mean was determined for each group.  
 Linear scale in the Y axis. 
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Figure 5.au: indicates arbitrary unit; amount obtained in 0,1 gr of stool. The amount was 
calculated for each mouse, and the geometric mean was determined for each group. Bars represent the 
geometric mean. Log-scale in the Y axis 
 
Significant differences in the number of total bacteria are not found 
among the treatment groups (FMD-i, FMD-14dRF, FMD 34dRF) and 
respective controls (Control 1, Control 2, Control 3). The amount of 
Lactobacillus group is decreased at the end of the FMD-i (p=0.0391) 
and reaches values equal to the respective controls after 14 days and 
34 days re-feeding. Interestingly, Bifidobacterium group levels 
increased after the 2° cycle of FMD-i (p=0.0152) respect to the control 
and returned to the initial levels after 14 days and 34 days re-feeding. 
The specie Faecalibacterium prausnitzii is more abundant in the 
FMD-i 14dRF respect to the Control 2 but the levels are equal at the 
Control 1. Changes have not involved the Enterobacteriaceae group. 
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2.6 DISCUSSION 
 
The gut microbiota plays the principal role to maintaining human 
health (Chung and Kasper, 2010) and its homeostasis is inexorably 
altered by age-related physiological changes in the gastrointestinal 
tract induced not only by the aging process itself, but also by 
modifications in lifestyle, nutritional behavior, and functional 
reduction of the host immune system (Biagi et al., 2011). In turn, the 
age-related gut microbiota alterations influence the aging process in 
the host, principally, immunosenescence, age-dependent inflammatory 
status and its complications from metabolic syndrome – diabetes, 
cardiovascular diseases (CDs), and cancer – and cognitive decline – 
dementia and Alzheimer’s disease (AD) (Candore et al. 2008).  
Diet is known to modulate the composition of the microbiota in 
humans and mice. Short-term consumption of diets composed entirely 
of animal or plant products alters microbial community structure 
(David et al., 2014) and alterations in the gut microbiome may 
contribute to the improvement in health from DR and time-restricted 
feeding. Thus, the aim of my study was to investigate the effects of 
STS and FMD in the gut microbiota of mice to assess whether some 
beneficial effects of these diets on the health can be attributed to their 
ability to manipulating the microbiota. The study on the nude mouse 
model has permitted to verify the effects in an immune-deficient 
condition, considering a contest in which the immune system is 
compromised. Recent studies show that the gut microbiota can 
influence immunosenescence or an inflammatory status and viceversa 
a different immune system reactivity, or an host genetic variation in 
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immunity- related pathways, can modulate the microbiota composition 
(Salzman et al., 2010; Blekhman et al., 2015, Lupp et al., 2007). From 
the data obtained in the “nude mice experiments”, it was observed that 
both the dietary interventions, STS and FMD; act in similar manner. 
In particular, STS has reduced the total bacteria number that increased 
after 1 week refeeding, also FMD has reduced the amount of the total 
bacteria which, in contrast to the STS-RF mice, doesn’t reach the 
initial levels after 7 days re-feeding. Significant changes in the amount 
of the total bacteria are not observable in the wild type old mice; 
probably the immune system contributes to maintain stable the 
number of the total bacteria in the gut.  
Interestingly,  the abundance of Lactobacillus group was significantly 
lower at the end of STS and FMD respect to the “Baseline” levels and 
reaches the initial levels after 1 week re-feeding in the nude mice, also 
in the wild-type mice the FMD-i reduces the Lactobacillus levels 
which increase again after 14 days and 34 days re-feeding. These 
results are consistent with a recent study in which time-restricted 
feeding during 8 hr of the dark phase decreased representation of the 
Lactobacillus species in mice fed with high-fat diet (Zarrinpar et al., 
2014), similarly to the results shown in Table 2 where, in mice 
undergo high fat diet, the amount of Lactobacillus drops down after 
FMD treatment. Recent studies have shown an association between 
several Lactobacillus species and obesity (Joyce et al., 2014, Million 
et al 2012, Million et al 2013); in particular a decrease in 
Lactobacillus species protects against metabolic disorders associated 
to obesity, perhaps by altering bile acids in the lumen (Li et al., 2013). 
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On the light of these observations, the FMD could have a protective 
effect against obesity and metabolic disorders. 
As evidenced by results, cycles of FMD increase the abundance of the 
Bifidobacterium group at the end of the diet, except in the nude mice 
where the Bifidobacterium increases after 1 week re-feeding. The 
Bifidobacterium species have been shown to lower intestinal LPS 
levels and to improve mucosal barrier function in Balb/c mice 
(Griffiths et al., 2004). Moreover, one of the most notable change in 
the elderly gut is the decreasing of the beneficial bifidobacteria levels. 
A wide number of bifidobacterial species are observed in infants and 
young adults, however, only few species are found in the elderly 
population, in particular Bifidobacterium adolescentis and 
Bifidobacterium longum. (Gavini et al., 2001). The FMD could 
improve health effects through increasing the abundance of 
Bifidobacterium in elderly. A recent study showed that commensal 
Bifidobacterium alone, transplanted in Balb/c mice, improved tumor 
control to the same degree as programmed cell death protein 1 ligand 
1 (PD-L1)-specific antibody therapy, and combination treatment 
nearly abolished melanoma tumor outgrowth (Silvan et al., 2015). 
 In the nude mice, higher values of Enterobacteriaceae are observable 
at the end of STS and FMD, the values become lower and more 
consistent after re-feeding. We did not observe the same in the wild-
type mice, in which the levels are maintained lower in all of the 
conditions. Probably the immune system still contributes to restrain 
their number.  
The amount of Faecalibacterium prausnitzii did not differ between 
the mice groups analyzed, except in the STS-RF group of nude mice, 
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in which the number is higher respect to the baseline, also in the wild-
type mice the number of Faecalibacterium prausnitzii is higher in the 
FMD-i 14dRF respect to the relative control (Control 2) but did not 
differ respect the other controls (Control 1 and Control 3). 
Faecalibacterium prausnitzii, saccharolytic bacteria positively 
correlated at the carbohydrate fermentation, is one of the dominant 
butyrate-producing bacteria detected in human feces and plays a 
beneficial role in the intestinal mucosa through the multiple effects of 
butyrate as the preferred energy source for the colonocytes and it is 
also considered to have additional anti-inflammatory properties that 
are suggested by cellular studies and experimental colitis models in 
mice (Martin et al., 2015) 
These data show that the FMD manipulates the gut microbiota in the 
mice and this study provide a basis from which to consider the 
functional consequences of the gut microbiota modified by the diet, 
which could contribute to the beneficial effects, previously described, 
of the fasting and fasting mimicking diet, especially in the metabolism 
and immunity. Experimental fecal transplantations in mice of 
microbiota associated to the FMD could be revealing of their causal 
role. It will be important to determine if similar shifts in the bacterial 
populations occur in the context of humans undergoing analogous 
“yo-yo” diets, reflecting alternating periods of increased and 
decreased caloric intake (Atkinson et al. 1994). It is interesting to 
consider whether or not the observed microbial plasticity may be a 
selective trait that helped our ancestors maintain energy balance given 
a volatile diet that was dependent on season and foraging success 
(Hawkes et al., 1991). This concept is concord with the view that the 
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effects of the CR on aging and diseases are responses evolved in 
mammals to adapt to periods of limited availability of food (Fontana 
and Klein, 2007; Fontana et al., 2010; Masoro, 2005; Weindruch and 
Walford, 1988).  
This present thesis strengthen the suggestion of the role played by 
fasting and “fasting mimicking diet” as an effective intervention to 
promote longevity and health span.  
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2.7 MATERIALS AND METHODS 
 
DNA extraction and Real-time PCR 
The fecal samples have been collected, from the cages for the 
experiments 1 and 2 (Table1 and Table 2), from the distal colon for 
the other experiments, and storage at -80°C until DNA extraction. The 
bacterial DNA was extracted from each fecal sample (0.1 gr) 
according to the MOBIO kit instructions and kept at -20°C until use. 
The DNA was normalized to a concentration of 1.0  ng/ul, measured 
by Nanodrop for subsequent real-time qPCR assay. The main bacterial 
groups of the intestinal microbiota were quantified by real- time qPCR 
using specific primers, previously published (Fujimoto et al., 2013; 
Langendijk et al., 1995; Bartosch et al., 2004; Cano et al., 2010; 
Walter et al., 2000) (Table 3). A Thermal Cycler CFX96 Touch Bio-
rad, associated with a Software (Bio-rad CFX manager 3.1 version) 
was used for the real-time PCR. Each reaction was done in duplicate 
in a volume of 25 ul with 96 –well optical-grade PCR plates (Bio-rad). 
Amplification were done with the following temperature profiles: one 
cycle 95°C 5 min, 39 cycles of denaturation at 95°C (15 sec). Standard 
curves of each bacterial group were generated from serial dilutions 
using DNA of known concentration extracted from a “control 
sample”, to compare the Ct values obtained in every qPCR reaction 
respect to it. Melt curve analyses were made by heating the PCR 
mixtures from 55 C° to 95°C with simultaneous measurements of the 
SYBR Green signal intensities.  
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Mice Diets 
The FMD is a plant-based diet based on a nutritional screen that 
identified ingredients that allow nourishment during periods of low 
calorie consumption (Brandhorst et al., 2013). The FMD consists of 
two different components designated as day 1 diet and day 2–4 diet 
that were fed in this respective order. The day 1 diet consists of a mix 
of various low-calorie broth powders, a vegetable medley powder, 
extra virgin olive oil, and essential fatty acids; day 2–4 diet consist of 
low-calorie broth powders and glycerol. Both formulations were then 
substituted with hydrogel (Clear H2O) to achieve binding and to allow 
the supply of the food in the cage feeders. Day 1 diet contains 7.67 
kJ/g (provided at 50% of normal daily intake; 0.46 kJ/g protein, 2.2 
kJ/g carbohydrate, 5.00 kJ/g fat); the day 2–4 diet is identical on all 
feeding days and contains 1.48 kJ/g (provided at 10% of normal daily 
intake; 0.01 kJ/g protein/fat, 1.47 kJ/g carbohydrates). At the end of 
the diet, we supplied chow ad libitum for 10 days before starting 
another FMD cycle. Prior to the FMD, animals were transferred into 
fresh cages to avoid feeding on residual chow and coprophagy. 
 
 
 
 
 
 
 
 
 
81 
Table 3 Specific- primers groups 
Target bacterial 
Group/Species 
Designation Primers (5’-3’)Sequence 
Annealing 
Temperatur
e 
Total bacteria 
HAD F 
HAD R 
TGGCTCAGGACGAACGCTGGCG
GC 
CCTACTGCTGCCTCCCGTAGGAG
T 
59°C 
Bifidobacterium 
group 
Bif164F 
Bif601R 
GGGTGGTAATGCCGGATG  
TAAGCCATGGACTTTCACACC 
58°C 
Lactobacillus 
group 
Lac F  
Lac R 
AGCAGTAGGGAATCTTCCA  
ATTYCACCGCTACACATG 
61°C 
Enterobacteriace
ae group 
Entero F 
Entero R 
CATTGACGTTACCCGCAGAAGA
AGC  
CTCTACGAGACTCAAGCTTGC 
63°C 
Faecalibacterium 
prausnitzii 
Frp-2F 
Fprau645
R 
GGAGGAAGAAGGTCTTCGG 
AATTCCGCCTACCTCTGCACT 
55°C 
(Fujimoto et al., 2013; Langendijk et al., 1995; Bartosch et al., 2004; 
Cano et al., 2010; Walter et al., 2000) 
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